메뉴 건너뛰기




Volumn 17, Issue 16, 2007, Pages 4562-4567

Benzo[b]thiophene-based histone deacetylase inhibitors

Author keywords

Anticancer drug; Benzo b thiophene; HDAC; HDAC inhibitor; Histone deacetylase inhibitor; Hydroxamic acids; SAHA

Indexed keywords

BENZOTHIOPHENE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE; RALOXIFENE; ZILEUTON;

EID: 34447309733     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.05.091     Document Type: Article
Times cited : (43)

References (23)
  • 8
    • 34447338629 scopus 로고    scopus 로고
    • note
    • HDAC activity (enzymatic) was evaluated with epitope-tagged human HDAC1 complex immuno-purified from stably expressing mammalian cells and substrate from Biomol Research Laboratories, Inc., Plymouth Meeting, PA. Cell-based HDAC activity was studied in a MTS assay using murine erythroleukemia cells (SC-9) incubated with vehicle or increasing concentrations of compound for 48 h. For full details, see: Miller, T. A.; Witter, D. J.; Belvedere, S. Preparation of thiophene and benzothiophene hydroxamic acid derivatives as histone deacetylase inhibitors. WO2005034880, 2005.
  • 9
    • 34447338892 scopus 로고    scopus 로고
    • note
    • Structure-activity relationships of additional scaffolds will be highlighted in due course.
  • 11
    • 34447311964 scopus 로고    scopus 로고
    • Dellaria, J. F. US Patent 6,207,701, 2001.
  • 19
    • 34447315573 scopus 로고    scopus 로고
    • note
    • +) 327.28. Additional experimental details and spectral data can be found in Ref. 5.
  • 20
    • 34447341213 scopus 로고    scopus 로고
    • Hamblett, C. L.; Methot, J. L.; Mampreian, D. M.; Sloman, D. L.; Stanton, M. G.; Kral, A. M.; Fleming, J.; Cruz, J. C.; Chenard, M.; Ozerova, N.; Hitz, A. M.; Wang, H.; Deshmukh, S. V.; Harsch, A.; Middleton, R. E.; Mosley, R. T.; Secrist, J. P.; Miller, T. Bioorg. Med. Chem. Lett., to be submitted.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.